Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I-III Clinical Trials. [electronic resource]
Producer: 20180105Description: 1707-1726 p. digitalISSN:- 1865-8652
- Aged
- Benzhydryl Compounds -- adverse effects
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Diabetes Mellitus, Type 2 -- drug therapy
- Dose-Response Relationship, Drug
- Drug-Related Side Effects and Adverse Reactions -- etiology
- Female
- Glucosides -- adverse effects
- Humans
- Hypoglycemic Agents -- adverse effects
- Incidence
- Male
- Middle Aged
- Randomized Controlled Trials as Topic
- Sulfonylurea Compounds -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.